These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 338625)

  • 21. Ampicillin and ampicillin-sulbactam dilution tests with mixed cultures of Bacteroides fragilis, Escherichia coli and Enterococcus.
    Heilmann F
    Infection; 1993; 21(3):187-90. PubMed ID: 8365818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunological detection of Bacteroides fragilis in clinical samples.
    Patrick S; Stewart LD; Damani N; Wilson KG; Lutton DA; Larkin MJ; Poxton I; Brown R
    J Med Microbiol; 1995 Aug; 43(2):99-109. PubMed ID: 7629860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of metronidazole on Escherichia coli in the presence of Bacteroides fragilis: an investigation in mice.
    Reznikov M; McDonald PJ
    Chemotherapy; 1983; 29(3):225-9. PubMed ID: 6347547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluorescent antibody test kit for rapid detection and identification of members of the Bacteroides fragilis and Bacteroides melaninogenicus groups in clinical specimens.
    Holland RW; Stauffer LR; Altemeier WA
    J Clin Microbiol; 1979 Aug; 10(2):121-7. PubMed ID: 41847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the abscess environment on the antimicrobial activity of ciprofloxacin.
    Bryant RE; Mazza JA
    Am J Med; 1989 Nov; 87(5A):23S-27S. PubMed ID: 2589367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of oxygen radicals and peroxide on survival after ultraviolet irradiation and liquid holding recovery of Bacteroides fragilis.
    Slade HJ; Jones DT; Woods DR
    J Bacteriol; 1981 Aug; 147(2):685-7. PubMed ID: 7263618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Escherichia coli and Bacteroides fragilis on peritoneal host defenses.
    Dunn DL; Barke RA; Ewald DC; Simmons RL
    Infect Immun; 1985 May; 48(2):287-91. PubMed ID: 3886544
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimicrobial effect of amniotic fluid.
    Thadepalli H; Bach VT; Davidson EC
    Obstet Gynecol; 1978 Aug; 52(2):198-204. PubMed ID: 355963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of amoxycillin and benzylpenicillin combined with clavulanic acid against Bacteroides fragilis in vitro and in experimentally infected mice.
    Dijkmans BA; Vaishnav J; Mattie H
    Scand J Infect Dis; 1985; 17(3):311-21. PubMed ID: 3903976
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Novel Selective Medium for Isolation of Bacteroides fragilis from Clinical Specimens.
    Ho PL; Ho LY; Yau CY; Tong MK; Chow KH
    J Clin Microbiol; 2017 Feb; 55(2):384-390. PubMed ID: 27852672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aggregation by fragilis and non-fragilis Bacteroides strains in vitro.
    Blake M; Rotstein OD; Llano M; Girotti MJ; Reid G
    J Med Microbiol; 1989 Jan; 28(1):9-14. PubMed ID: 2536442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cloning and expression of the Bacteroides fragilis TAL2480 neuraminidase gene, nanH, in Escherichia coli.
    Russo TA; Thompson JS; Godoy VG; Malamy MH
    J Bacteriol; 1990 May; 172(5):2594-600. PubMed ID: 2158974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attempted transfer of antibiotic resistance between Bacteroides and Escherichia coli.
    Del Bene VE; Rogers M; Farrar WE
    J Gen Microbiol; 1976 Feb; 92(2):384-90. PubMed ID: 768412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A tissue culture model for study of growth promotion and antimicrobial susceptibility in Bacteroides fragilis.
    Claesson BE; Gotthardsson IH
    J Antimicrob Chemother; 1988 Jan; 21(1):17-26. PubMed ID: 3128520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. beta-Lactamase activity in human pus.
    Bryant RE; Rashad AL; Mazza JA; Hammond D
    J Infect Dis; 1980 Oct; 142(4):594-601. PubMed ID: 6969281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative efficacy of ceftriaxone in experimental infections involving Bacteroides fragilis and Escherichia coli.
    Dezfulian M; Bitar RA; Bartlett JG
    Chemotherapy; 1993; 39(5):355-60. PubMed ID: 8370326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model.
    Hermsen ED; Hovde LB; Sprandel KA; Rodvold KA; Rotschafer JC
    Antimicrob Agents Chemother; 2005 Feb; 49(2):685-9. PubMed ID: 15673752
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of anaerobic bacteria in intra-abdominal septic abscesses in mediating septic control of skeletal muscle glucose oxidation and lactic acidemia.
    Vary TC; Siegel JH; Tall B; Morris JG
    J Trauma; 1989 Jul; 29(7):1003-13; discussion 1013-4. PubMed ID: 2664200
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental intra-abdominal abscesses in rats: quantitative bacteriology of infected animals.
    Onderdonk AB; Weinstein WM; Sullivan NM; Bartlett JG; Gorbach SL
    Infect Immun; 1974 Dec; 10(6):1256-9. PubMed ID: 4611923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accumulation of norfloxacin by Bacteroides fragilis.
    Ricci V; Piddock LJ
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2361-6. PubMed ID: 10952580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.